Avaleht › HIV › Texas › Houston
HIV kliinilised uuringud linnas Houston, TX
17 uuringut haiguse HIV jaoks otsivad osalejaid linnas Houston ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
VärbamineVaatlusuuring
- UT Health, Houston
- Thomas Street at Quentin Mease Health Center, Houston
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
VärbamineFaas 3
- GSK Investigational Site, Houston
ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
Värbamine
- Baylor College of Medicine, Houston
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
VärbamineFaas 2/3
- Saint Hope Foundation, Inc. ( Site 1504), Bellaire · 7 mi kaugusel
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
VärbamineFaas 1/2
- 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
VärbamineFaas 2
- M D Anderson Cancer Center, Houston
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
VärbamineFaas 1Terved vabatahtlikud oodatud
- The Crofoot Research Center, Houston
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
Värbamine
- University of Texas M.D. Anderson Cancer Center, Houston
Positive Peers Intervention Clinical Trial
Värbamine
- Thomas Street Clinic, Houston
Screen2Prevent (S2P)
VärbamineTerved vabatahtlikud oodatud
- Baylor College of Medicine, Houston
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
VärbamineFaas 2
- UT Health Houston, Houston
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
VärbamineFaas 2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Bellaire · 7 mi kaugusel
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Värbamine
- Houston Methodist Research Institute, Houston
Menopausal HT for Women Living With HIV (HoT)
VärbamineFaas 4
- Houston AIDS Research Team CRS (31473), Houston
Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
Värbamine
- The University of Texas Health Science Center at Houston, Houston
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
VärbamineFaas 2
- UT Health Houston, Houston
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
VärbamineFaas 1/2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
HIV uuringud teistes linnades
- Washington, DC22 uuringut
- New York City, NY19 uuringut
- Miami, FL17 uuringut
- Baltimore, MD16 uuringut
- San Francisco, CA15 uuringut
- Atlanta, GA14 uuringut
- Chicago, IL14 uuringut
- Boston, MA11 uuringut
- Philadelphia, PA11 uuringut
- San Diego, CA10 uuringut
- Los Angeles, CA9 uuringut
- Seattle, WA8 uuringut
Muud uuringud linnas Houston
- Mitteväikerakuline kopsuvähk145 uuringut
- Rinnavähk126 uuringut
- Vähk (kõik liigid)121 uuringut
- Metastaatiline vähk104 uuringut
- Käär- ja pärasoolevähk102 uuringut
- Munasarjavähk89 uuringut
- Äge müeloidne leukeemia85 uuringut
- Kopsuvähk78 uuringut
- Eesnäärmevähk76 uuringut
- Endomeetriumivähk68 uuringut
- Pankreasevähk61 uuringut
- Melanoom59 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.